Synthetic Biologics, Inc. (SYN)
R&D to Revenue
0.00%
Quarterly · Period ending:
SYN R&D to Revenue
Latest reported0.00%period ending
Latest reported0.00%period ending
SYN Quarterly R&D/Revenue (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
SYN r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 118.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -261.1894% | |
| 98.481% | |
| 78.6476% | |
| 71.8944% | |
| 28.0185% | |
| 146.456% | |
| 25.6267% | |
| 698.2345% | |
| -29.2381% | |
| 637.4905% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 333.6667% | |
| 0% | |
| 0% | |
| 16,221.36% | |
| 0% | |
| 0% | |
| 0% | |
| 278.9886% | |
| 578.5839% | |
| 498.2811% | |
| 1,935.4378% | |
| 709.0117% | |
| 744.4277% | |
| 341.2856% | |
| 900% | |
| 800% | |
| 700% | |
| 0% |